Teratai Capital is a venture capital firm pursuing a long-term approach to investing in leading global companies that demonstrate exceptional potential for sustainable growth.

With £185M assets under management, our approach combines capital deployment with active management, leveraging our deep operational expertise and extensive network to empower visionary entrepreneurs across early to growth stages.

Our mission is to generate world-class returns for our investors while maintaining the highest standards of excellence, integrity, and partnership that make our employees, partners, and portfolio companies proud. This commitment to excellence drives every aspect of our investment approach and organizational culture.

Venture Capital

Our venture practice focuses on identifying and investing in exceptional companies across early through late-stage opportunities. Drawing on our extensive experience investing across global markets, we combine deep market insights with a hands-on partnership approach to help founders build category-defining businesses. Our cross-border expertise enables us to identify unique opportunities and provide strategic value beyond capital, leveraging our extensive network across key global markets.

Growth Equity

Our growth equity strategy targets investments in high-potential companies demonstrating strong fundamentals and clear paths to market leadership. We employ a disciplined investment approach focused on businesses with proven unit economics and sustainable competitive advantages. Through active partnership and strategic guidance, we help accelerate value creation while maintaining a long-term perspective on sustainable growth. Our team’s deep operational expertise and global network provide portfolio companies with unique advantages in scaling their operations and entering new markets.

Cookie Notice

By using our website, you agree to our use of cookies. We use cookies to enhance site navigation and analyze site usage. Your personal data is handled in accordance with our Privacy Policy.